Wyoming MPJE (Pharmacy Jurisprudence) Practice Exam

What is fast track review?

1. It allows the sale of drug samples post-clinical trials

2. It delays the clinical trials process

3. It expedites the clinical trials process from the investigational new drug application

4. It is used for drugs already reviewed by the FDA

The correct answer is: It allows the sale of drug samples post-clinical trials

Fast track review is a process used by the Food and Drug Administration (FDA) to speed up the review of drugs that treat serious conditions and fill an unmet medical need. This option allows the sale of drug samples after the completion of clinical trials, giving patients faster access to potentially life-saving treatments. Option B is incorrect as it implies that fast track review delays the clinical trials process, when in fact it expedites it. Option C is incorrect as it specifically states the investigational new drug application, while the fast track review process applies to all stages of clinical trials. Option D is incorrect as it suggests that fast track review is only used for drugs that have already been reviewed by the FDA, when in fact it is used for drugs at all stages of review.